newsfilter
← Latest News
PR Newswire·

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that the German Association of...